NEW YORK (GenomeWeb) – Utah-based bioinformatics company Tute Genomics said today it closed a second Series A1 round of venture capital funding in which it raised over $3.9 million.

A company representative told GenomeWeb that Tute will use the funds to scale up its commercialization efforts including expanding its sales and marketing, and engineering teams. It has set aside funds from the new capital to hire a vice president of sales, a vice president of marketing, and a chief scientific officer.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.